(AP)—Drug giant Pfizer Inc. said Thursday that its third-quarter profit fell 14 percent as sales plunged, mainly due to U.S. generic competition to cholesterol fighter Lipitor, long the world's top-selling drug.
Nov 1, 2012
0
0
(AP)—Pfizer said Monday it will buy NextWave Pharmaceuticals Inc., a company that makes a liquid attention deficit hyperactivity disorder drug, in a deal worth as much as $700 million.
Oct 22, 2012
0
0
A simple, five-question patient-administered survey (COPD-PS) may lead to increased diagnoses of chronic obstructive pulmonary disease (COPD).
Oct 22, 2012
0
0
Thailand has approved an affordable generic version of the anti-impotence drug Viagra to go on sale next week, as the country looks to combat rampant counterfeit production, officials said Wednesday.
Sep 26, 2012
0
0
(AP)—Advisers to European Union regulators have recommended approval of a new anti-clotting drug for use by adults with a common irregular heart rhythm that boosts risk of strokes or blood clots, drugmakers Bristol-Myers ...
Sep 21, 2012
0
0
(AP)—Pharmaceutical industry heavyweights are teaming up to address a challenge that's long vexed drugmakers: how to improve the way experimental drugs are tested so they can get approved, and reach patients, faster.
Sep 19, 2012
0
0
More than 100 years after it was first caught in the act of decaying a patient's brain, Alzheimer's remains one of medicine's greatest challenges as it robs ever more people of their memory and independence.
Sep 17, 2012
1
0
An experimental drug that failed to stop mental decline in Alzheimer's patients in the U.S. and Canada also showed some potential benefit in slowing brain plaque, fuller results of two major studies show.
Sep 11, 2012
0
0
Pfizer Inc. says the Food and Drug Administration on Tuesday approved its new drug to treat a rare form of blood and bone marrow cancer.
Sep 4, 2012
0
0
(HealthDay)—For patients with poorly controlled asthma, the addition of tiotropium to standard therapy is beneficial, according to a study published online Sept. 3 in the New England Journal of Medicine to coincide with ...
Sep 4, 2012
0
0
